These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35681079)

  • 1. Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
    Rempel E; Kluck K; Beck S; Ourailidis I; Kazdal D; Neumann O; Volckmar AL; Kirchner M; Goldschmid H; Pfarr N; Weichert W; Hübschmann D; Fröhling S; Sutter C; Schaaf CP; Schirmacher P; Endris V; Stenzinger A; Budczies J
    NPJ Precis Oncol; 2022 Jun; 6(1):36. PubMed ID: 35681079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
    Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
    Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).
    Menzel M; Endris V; Schwab C; Kluck K; Neumann O; Beck S; Ball M; Schaaf C; Fröhling S; Lichtner P; Schirmacher P; Kazdal D; Stenzinger A; Budczies J
    Transl Oncol; 2023 Sep; 35():101706. PubMed ID: 37327584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types.
    Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N
    JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34423229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.
    Budczies J; Kluck K; Beck S; Ourailidis I; Allgäuer M; Menzel M; Kazdal D; Perkhofer L; Kleger A; Schirmacher P; Seufferlein T; Stenzinger A
    J Pathol Clin Res; 2022 Jul; 8(4):371-382. PubMed ID: 35384413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients.
    Zong H; Zhang J; Xu Z; Pan JN; Wang R; Han J; Jiang M; Ren R; Zang L; Wang H; Cao WM
    J Cancer; 2022; 13(4):1119-1129. PubMed ID: 35281878
    [No Abstract]   [Full Text] [Related]  

  • 7. Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types.
    Takamatsu S; Brown JB; Yamaguchi K; Hamanishi J; Yamanoi K; Takaya H; Kaneyasu T; Mori S; Mandai M; Matsumura N
    JCO Precis Oncol; 2022 May; 6():e2200085. PubMed ID: 35613413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer.
    Wen H; Feng Z; Ma Y; Liu R; Ou Q; Guo Q; Shen Y; Wu X; Shao Y; Bao H; Wu X
    BMC Cancer; 2022 May; 22(1):550. PubMed ID: 35578198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-Cancer Analysis of
    Sokol ES; Pavlick D; Khiabanian H; Frampton GM; Ross JS; Gregg JP; Lara PN; Oesterreich S; Agarwal N; Necchi A; Miller VA; Alexander B; Ali SM; Ganesan S; Chung JH
    JCO Precis Oncol; 2020; 4():442-465. PubMed ID: 32903788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial Cancers in
    Smith ES; Da Cruz Paula A; Cadoo KA; Abu-Rustum NR; Pei X; Brown DN; Ferrando L; Sebastiao APM; Riaz N; Robson ME; Soslow RA; Reis-Filho JS; Mandelker D; Weigelt B
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial.
    Bonnet E; Haddad V; Quesada S; Baffert KA; Lardy-Cléaud A; Treilleux I; Pissaloux D; Attignon V; Wang Q; Buisson A; Heudel PE; Bachelot T; Dufresne A; Eberst L; Toussaint P; Bonadona V; Lasset C; Viari A; Sohier E; Paindavoine S; Combaret V; Pérol D; Ray-Coquard I; Blay JY; Trédan O
    J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer.
    Sztupinszki Z; Diossy M; Borcsok J; Prosz A; Cornelius N; Kjeldsen MK; Mirza MR; Szallasi Z
    Clin Cancer Res; 2021 Oct; 27(20):5681-5687. PubMed ID: 34380641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous Recombination Abnormalities Associated With
    Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A
    Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
    Telli ML; Timms KM; Reid J; Hennessy B; Mills GB; Jensen KC; Szallasi Z; Barry WT; Winer EP; Tung NM; Isakoff SJ; Ryan PD; Greene-Colozzi A; Gutin A; Sangale Z; Iliev D; Neff C; Abkevich V; Jones JT; Lanchbury JS; Hartman AR; Garber JE; Ford JM; Silver DP; Richardson AL
    Clin Cancer Res; 2016 Aug; 22(15):3764-73. PubMed ID: 26957554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma.
    Takaya H; Nakai H; Takamatsu S; Mandai M; Matsumura N
    Sci Rep; 2020 Feb; 10(1):2757. PubMed ID: 32066851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Determinants of Homologous Recombination Deficiency across Human Cancers.
    Qing T; Wang X; Jun T; Ding L; Pusztai L; Huang KL
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer.
    Shao C; Chang MS; Lam FC; Marley AR; Tang H; Song Y; Miller C; Brown M; Wan I; Han J; Adeboyeje G
    J Oncol; 2022; 2022():5830475. PubMed ID: 35909902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation.
    Sahajpal NS; Mondal AK; Vashisht A; Singh H; Pang AWC; Saul D; Nivin O; Hilton B; DuPont BR; Kota V; Savage NM; Hastie AR; Chaubey A; Kolhe R
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer.
    Wu X; Wang Q; Liu P; Sun L; Wang Y
    Front Genet; 2022; 13():1026871. PubMed ID: 36468004
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
    da Costa AABA; do Canto LM; Larsen SJ; Ribeiro ARG; Stecca CE; Petersen AH; Aagaard MM; de Brot L; Baumbach J; Baiocchi G; Achatz MI; Rogatto SR
    BMC Cancer; 2019 May; 19(1):422. PubMed ID: 31060523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.